Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-19-020315
Filing Date
2019-04-18
Accepted
2019-04-18 17:57:51
Documents
1
Period of Report
2018-11-19

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tv519200_4.html 4  
1 OWNERSHIP DOCUMENT tv519200_4.xml 4 3904
  Complete submission text file 0001144204-19-020315.txt   5460
Mailing Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219
Business Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219 2149055100
ABEONA THERAPEUTICS INC. (Issuer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
CARR EDWARD (Reporting) CIK: 0001273351 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-15771 | Film No.: 19756794